{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:07:25Z","timestamp":1794006445104,"version":"4.8.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T00:00:00Z","timestamp":1539734400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41590-018-0225-9","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T11:50:08Z","timestamp":1539345008000},"page":"1159-1168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["The value of transcriptomics in advancing knowledge of the immune response and diagnosis in tuberculosis"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6941-3618","authenticated-orcid":false,"given":"Akul","family":"Singhania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2753-1800","authenticated-orcid":false,"given":"Robert J.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Rodrigue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1572-5421","authenticated-orcid":false,"given":"Pranabashis","family":"Haldar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9845-6134","authenticated-orcid":false,"given":"Anne","family":"O\u2019Garra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,17]]},"reference":[{"key":"225_CR1","unstructured":"World Health Organization. Global Tuberculosis Report (World Health Organization, 2017)."},{"key":"225_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","volume":"31","author":"A O\u2019Garra","year":"2013","unstructured":"O\u2019Garra, A. et al. The immune response in tuberculosis. Annu. Rev. Immunol. 31, 475\u2013527 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"225_CR3","doi-asserted-by":"publisher","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","volume":"2","author":"M Pai","year":"2016","unstructured":"Pai, M. et al. Tuberculosis. Nat. Rev. Dis. Primers. 2, 16076 (2016).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"225_CR4","first-page":"1226","volume":"12","author":"PD Davies","year":"2008","unstructured":"Davies, P. D. & Pai, M. The diagnosis and misdiagnosis of tuberculosis. Int. J. Tuberc. Lung Dis. 12, 1226\u20131234 (2008).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"225_CR5","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1128\/JCM.35.9.2229-2234.1997","volume":"35","author":"GE Pfyffer","year":"1997","unstructured":"Pfyffer, G. E., Cieslak, C., Welscher, H. M., Kissling, P. & R\u00fcsch-Gerdes, S. Rapid detection of mycobacteria in clinical specimens by using the automated BACTEC 9000 MB system and comparison with radiometric and solid-culture systems. J. Clin. Microbiol. 35, 2229\u20132234 (1997).","journal-title":"J. Clin. Microbiol."},{"key":"225_CR6","unstructured":"Behr, M. A., Edelstein, P. H. & Ramakrishnan, L. Revisiting the timetable of tuberculosis. Br. Med. J. 362, k2738 (2018)."},{"key":"225_CR7","first-page":"601737","volume":"2013","author":"A Trajman","year":"2013","unstructured":"Trajman, A., Steffen, R. E. & Menzies, D. Interferon-\u03b3 release assays versus tuberculin skin testing for the diagnosis of latent tuberculosis infection: an overview of the evidence. Pulm. Med. 2013, 601737 (2013).","journal-title":"Pulm. Med."},{"key":"225_CR8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrmicro2236","volume":"7","author":"CE Barry III","year":"2009","unstructured":"Barry, C. E. III et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7, 845\u2013855 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"225_CR9","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/nm.4161","volume":"22","author":"H Esmail","year":"2016","unstructured":"Esmail, H. et al. Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-d-glucose positron emission and computed tomography. Nat. Med. 22, 1090\u20131093 (2016).","journal-title":"Nat. Med."},{"key":"225_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1164\/rccm.201207-1217OC","volume":"187","author":"DW Dowdy","year":"2013","unstructured":"Dowdy, D. W., Basu, S. & Andrews, J. R. Is passive diagnosis enough? The impact of subclinical disease on diagnostic strategies for tuberculosis. Am. J. Respir. Crit. Care Med. 187, 543\u2013551 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"225_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/ni.3048","volume":"16","author":"IM Orme","year":"2015","unstructured":"Orme, I. M., Robinson, R. T. & Cooper, A. M. The balance between protective and pathogenic immune responses in the TB-infected lung. Nat. Immunol. 16, 57\u201363 (2015).","journal-title":"Nat. Immunol."},{"key":"225_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","volume":"27","author":"AM Cooper","year":"2009","unstructured":"Cooper, A. M. Cell-mediated immune responses in tuberculosis. Annu. Rev. Immunol. 27, 393\u2013422 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"225_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/mi.2011.13","volume":"4","author":"AM Cooper","year":"2011","unstructured":"Cooper, A. M., Mayer-Barber, K. D. & Sher, A. Role of innate cytokines in mycobacterial infection. Mucosal Immunol. 4, 252\u2013260 (2011).","journal-title":"Mucosal Immunol."},{"key":"225_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","volume":"19","author":"JL Flynn","year":"2001","unstructured":"Flynn, J. L. & Chan, J. Immunology of tuberculosis. Annu. Rev. Immunol. 19, 93\u2013129 (2001).","journal-title":"Annu. Rev. Immunol."},{"key":"225_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1146\/annurev.immunol.20.081501.125851","volume":"20","author":"JL Casanova","year":"2002","unstructured":"Casanova, J. L. & Abel, L. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 20, 581\u2013620 (2002).","journal-title":"Annu. Rev. Immunol."},{"key":"225_CR16","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane, J. et al. Tuberculosis associated with infliximab, a tumor necrosis factor \u03b1-neutralizing agent. N. Engl. J. Med. 345, 1098\u20131104 (2001).","journal-title":"N. Engl. J. Med."},{"key":"225_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1146\/annurev-immunol-042617-053420","volume":"36","author":"H Esmail","year":"2018","unstructured":"Esmail, H. et al. The immune response to Mycobacterium tuberculosis in HIV-1-coinfected persons. Annu. Rev. Immunol. 36, 603\u2013638 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"225_CR18","doi-asserted-by":"publisher","first-page":"e1005739","DOI":"10.1371\/journal.ppat.1005739","volume":"12","author":"PL Lin","year":"2016","unstructured":"Lin, P. L. et al. PET CT identifies reactivation risk in cynomolgus macaques with latent M. tuberculosis. PLoS Pathog. 12, e1005739 (2016).","journal-title":"PLoS Pathog."},{"key":"225_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1017\/S0029665111003326","volume":"71","author":"AR Martineau","year":"2012","unstructured":"Martineau, A. R. Old wine in new bottles: vitamin D in the treatment and prevention of tuberculosis. Proc. Nutr. Soc. 71, 84\u201389 (2012).","journal-title":"Proc. Nutr. Soc."},{"key":"225_CR20","doi-asserted-by":"publisher","first-page":"20130426","DOI":"10.1098\/rstb.2013.0426","volume":"369","author":"C Dye","year":"2014","unstructured":"Dye, C. After 2015: infectious diseases in a new era of health and development. Phil. Trans. R. Soc. Lond. B 369, 20130426 (2014).","journal-title":"Phil. Trans. R. Soc. Lond. B"},{"key":"225_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/thorax.55.2.129","volume":"55","author":"M Llewelyn","year":"2000","unstructured":"Llewelyn, M., Cropley, I., Wilkinson, R. J. & Davidson, R. N. Tuberculosis diagnosed during pregnancy: a prospective study from London. Thorax 55, 129\u2013132 (2000).","journal-title":"Thorax"},{"key":"225_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O\u2019Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87\u2013103 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"225_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/infdis\/jit424","volume":"209","author":"PS Redford","year":"2014","unstructured":"Redford, P. S. et al. Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway. J. Infect. Dis. 209, 270\u2013274 (2014).","journal-title":"J. Infect. Dis."},{"key":"225_CR24","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09247","volume":"466","author":"MP Berry","year":"2010","unstructured":"Berry, M. P. et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973\u2013977 (2010).","journal-title":"Nature"},{"key":"225_CR25","doi-asserted-by":"publisher","first-page":"e46191","DOI":"10.1371\/journal.pone.0046191","volume":"7","author":"CI Bloom","year":"2012","unstructured":"Bloom, C. I. et al. Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy. PLoS One 7, e46191 (2012).","journal-title":"PLoS One"},{"key":"225_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/gene.2010.51","volume":"12","author":"J Maertzdorf","year":"2011","unstructured":"Maertzdorf, J. et al. Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun. 12, 15\u201322 (2011).","journal-title":"Genes Immun."},{"key":"225_CR27","doi-asserted-by":"publisher","first-page":"e26938","DOI":"10.1371\/journal.pone.0026938","volume":"6","author":"J Maertzdorf","year":"2011","unstructured":"Maertzdorf, J. et al. Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis. PLoS One 6, e26938 (2011).","journal-title":"PLoS One"},{"key":"225_CR28","doi-asserted-by":"publisher","first-page":"7853","DOI":"10.1073\/pnas.1121072109","volume":"109","author":"J Maertzdorf","year":"2012","unstructured":"Maertzdorf, J. et al. Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc. Natl. Acad. Sci. USA 109, 7853\u20137858 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"225_CR29","doi-asserted-by":"publisher","first-page":"e45839","DOI":"10.1371\/journal.pone.0045839","volume":"7","author":"TH Ottenhoff","year":"2012","unstructured":"Ottenhoff, T. H. et al. Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis. PLoS One 7, e45839 (2012).","journal-title":"PLoS One"},{"key":"225_CR30","doi-asserted-by":"publisher","first-page":"e70630","DOI":"10.1371\/journal.pone.0070630","volume":"8","author":"CI Bloom","year":"2013","unstructured":"Bloom, C. I. et al. Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PLoS One 8, e70630 (2013).","journal-title":"PLoS One"},{"key":"225_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/infdis\/jis499","volume":"207","author":"JM Cliff","year":"2013","unstructured":"Cliff, J. M. et al. Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J. Infect. Dis. 207, 18\u201329 (2013).","journal-title":"J. Infect. Dis."},{"key":"225_CR32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.coi.2013.08.003","volume":"25","author":"MP Berry","year":"2013","unstructured":"Berry, M. P., Blankley, S., Graham, C. M., Bloom, C. I. & O\u2019Garra, A. Systems approaches to studying the immune response in tuberculosis. Curr. Opin. Immunol. 25, 579\u2013587 (2013).","journal-title":"Curr. Opin. Immunol."},{"key":"225_CR33","doi-asserted-by":"publisher","first-page":"e0162220","DOI":"10.1371\/journal.pone.0162220","volume":"11","author":"S Blankley","year":"2016","unstructured":"Blankley, S. et al. The transcriptional signature of active tuberculosis reflects symptom status in extra-pulmonary and pulmonary tuberculosis. PLoS One 11, e0162220 (2016).","journal-title":"PLoS One"},{"key":"225_CR34","doi-asserted-by":"publisher","first-page":"e87238","DOI":"10.1172\/jci.insight.87238","volume":"1","author":"JK Roe","year":"2016","unstructured":"Roe, J. K. et al. Blood transcriptomic diagnosis of pulmonary and extrapulmonary tuberculosis. JCI Insight 1, e87238 (2016).","journal-title":"JCI Insight"},{"key":"225_CR35","doi-asserted-by":"publisher","first-page":"e1006687","DOI":"10.1371\/journal.ppat.1006687","volume":"13","author":"TJ Scriba","year":"2017","unstructured":"Scriba, T. J. et al. Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease. PLoS Pathog. 13, e1006687 (2017).","journal-title":"PLoS Pathog."},{"key":"225_CR36","doi-asserted-by":"publisher","first-page":"e73230","DOI":"10.1371\/journal.pone.0073230","volume":"8","author":"SA Joosten","year":"2013","unstructured":"Joosten, S. A., Fletcher, H. A. & Ottenhoff, T. H. A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis. PLoS One 8, e73230 (2013).","journal-title":"PLoS One"},{"key":"225_CR37","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1183\/13993003.02121-2015","volume":"47","author":"S Blankley","year":"2016","unstructured":"Blankley, S. et al. A 380-gene meta-signature of active tuberculosis compared with healthy controls. Eur. Respir. J. 47, 1873\u20131876 (2016).","journal-title":"Eur. Respir. J."},{"key":"225_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-017-0005-4","volume":"3","author":"A Sambarey","year":"2017","unstructured":"Sambarey, A. et al. Meta-analysis of host response networks identifies a common core in tuberculosis. NPJ Syst. Biol. Appl. 3, 4 (2017).","journal-title":"NPJ Syst. Biol. Appl."},{"key":"225_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04579-w","volume":"9","author":"A Singhania","year":"2018","unstructured":"Singhania, A. et al. A modular transcriptional signature identifies phenotypic heterogeneity of human tuberculosis infection. Nat. Commun. 9, 2308 (2018).","journal-title":"Nat. Commun."},{"key":"225_CR40","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1002\/eji.201344219","volume":"44","author":"A Dorhoi","year":"2014","unstructured":"Dorhoi, A. et al. Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics. Eur. J. Immunol. 44, 2380\u20132393 (2014).","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"225_CR41","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.1073\/pnas.091096998","volume":"98","author":"C. Manca","year":"2001","unstructured":"Manca, C. et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-\u03b1\/\u03b2. Proc. Natl. Acad. Sci. USA 98, 5752\u20135757 (2001).","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"11","key":"225_CR42","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1089\/jir.2005.25.694","volume":"25","author":"Claudia Manca","year":"2005","unstructured":"Manca, C. et al. Hypervirulent M. tuberculosis W\/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J. Interferon Cytokine Res. 25, 694\u2013701 (2005).","journal-title":"Journal of Interferon & Cytokine Research"},{"key":"225_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature13489","volume":"511","author":"KD Mayer-Barber","year":"2014","unstructured":"Mayer-Barber, K. D. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511, 99\u2013103 (2014).","journal-title":"Nature"},{"key":"225_CR44","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.4049\/jimmunol.1300146","volume":"191","author":"FW McNab","year":"2013","unstructured":"McNab, F. W. et al. TPL-2-ERK1\/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production. J. Immunol. 191, 1732\u20131743 (2013).","journal-title":"J. Immunol."},{"issue":"5","key":"225_CR45","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1084\/jem.20180325","volume":"215","author":"L\u00facia Moreira-Teixeira","year":"2018","unstructured":"Moreira-Teixeira, L., Mayer-Barber, K., Sher, A. & O\u2019Garra, A. Type I interferons in tuberculosis: foe and occasionally friend. J. Exp. Med. 215, 1273\u20131285 (2018).","journal-title":"The Journal of Experimental Medicine"},{"key":"225_CR46","doi-asserted-by":"publisher","first-page":"522","DOI":"10.4049\/jimmunol.179.1.522","volume":"179","author":"D Ordway","year":"2007","unstructured":"Ordway, D. et al. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J. Immunol. 179, 522\u2013531 (2007).","journal-title":"J. Immunol."},{"key":"225_CR47","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.4049\/jimmunol.1601138","volume":"197","author":"HP Gideon","year":"2016","unstructured":"Gideon, H. P., Skinner, J. A., Baldwin, N., Flynn, J. L. & Lin, P. L. Early whole blood transcriptional signatures are associated with severity of lung inflammation in cynomolgus macaques with Mycobacterium tuberculosis infection. J. Immunol. 197, 4817\u20134828 (2016).","journal-title":"J. Immunol."},{"key":"225_CR48","doi-asserted-by":"publisher","first-page":"e67277","DOI":"10.1371\/journal.pone.0067277","volume":"8","author":"J Carmona","year":"2013","unstructured":"Carmona, J. et al. Mycobacterium tuberculosis strains are differentially recognized by TLRs with an impact on the immune response. PLoS One 8, e67277 (2013).","journal-title":"PLoS One"},{"key":"225_CR49","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.chom.2015.05.005","volume":"17","author":"AC Collins","year":"2015","unstructured":"Collins, A. C. et al. Cyclic GMP-AMP synthase is an innate immune DNA sensor for Mycobacterium tuberculosis. Cell Host Microbe 17, 820\u2013828 (2015).","journal-title":"Cell Host Microbe"},{"key":"225_CR50","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.chom.2015.05.003","volume":"17","author":"R Wassermann","year":"2015","unstructured":"Wassermann, R. et al. Mycobacterium tuberculosis differentially activates cGAS- and inflammasome-dependent intracellular immune responses through ESX-1. Cell Host Microbe 17, 799\u2013810 (2015).","journal-title":"Cell Host Microbe"},{"key":"225_CR51","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.chom.2015.05.004","volume":"17","author":"RO Watson","year":"2015","unstructured":"Watson, R. O. et al. The cytosolic sensor cGAS detects Mycobacterium tuberculosis DNA to induce type I interferons and activate autophagy. Cell Host Microbe 17, 811\u2013819 (2015).","journal-title":"Cell Host Microbe"},{"key":"225_CR52","doi-asserted-by":"publisher","first-page":"e1005809","DOI":"10.1371\/journal.ppat.1005809","volume":"12","author":"KE Wiens","year":"2016","unstructured":"Wiens, K. E. & Ernst, J. D. The mechanism for type I interferon induction by Mycobacterium tuberculosis is bacterial strain-dependent. PLoS Pathog. 12, e1005809 (2016).","journal-title":"PLoS Pathog."},{"key":"225_CR53","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.4049\/jimmunol.1401088","volume":"193","author":"FW McNab","year":"2014","unstructured":"McNab, F. W. et al. Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-\u03b3 for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages. J. Immunol. 193, 3600\u20133612 (2014).","journal-title":"J. Immunol."},{"key":"225_CR54","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1172\/JCI40817","volume":"120","author":"LR Antonelli","year":"2010","unstructured":"Antonelli, L. R. et al. Intranasal poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte\/macrophage population. J. Clin. Invest. 120, 1674\u20131682 (2010).","journal-title":"J. Clin. Invest."},{"key":"225_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11812-x","volume":"7","author":"T Domaszewska","year":"2017","unstructured":"Domaszewska, T. et al. Concordant and discordant gene expression patterns in mouse strains identify best-fit animal model for human tuberculosis. Sci. Rep. 7, 12094 (2017).","journal-title":"Sci. Rep."},{"key":"225_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0286-2","volume":"5","author":"S Namasivayam","year":"2017","unstructured":"Namasivayam, S. et al. Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy. Microbiome 5, 71 (2017).","journal-title":"Microbiome"},{"key":"225_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10346-6","volume":"7","author":"MF Wipperman","year":"2017","unstructured":"Wipperman, M. F. et al. Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed. Sci. Rep. 7, 10767 (2017).","journal-title":"Sci. Rep."},{"key":"225_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02611-z","volume":"9","author":"G Zhang","year":"2018","unstructured":"Zhang, G. et al. A proline deletion in IFNAR1 impairs IFN-signaling and underlies increased resistance to tuberculosis in humans. Nat. Commun. 9, 85 (2018).","journal-title":"Nat. Commun."},{"key":"225_CR59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature13801","volume":"517","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. Human intracellular ISG15 prevents interferon-\u03b1\/\u03b2 over-amplification and auto-inflammation. Nature 517, 89\u201393 (2015).","journal-title":"Nature"},{"key":"225_CR60","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1126\/science.1224026","volume":"337","author":"D Bogunovic","year":"2012","unstructured":"Bogunovic, D. et al. Mycobacterial disease and impaired IFN-\u03b3 immunity in humans with inherited ISG15 deficiency. Science 337, 1684\u20131688 (2012).","journal-title":"Science"},{"key":"225_CR61","first-page":"702","volume":"73","author":"DY Chen","year":"2008","unstructured":"Chen, D. Y. et al. Single-chain antibody against human lipocalin-type prostaglandin D synthase: construction, expression, purification, and activity assay. Biochemistry 73, 702\u2013710 (2008).","journal-title":"Biochemistry"},{"key":"225_CR62","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.it.2015.03.005","volume":"36","author":"M Divangahi","year":"2015","unstructured":"Divangahi, M., King, I. L. & Pernet, E. Alveolar macrophages and type I IFN in airway homeostasis and immunity. Trends Immunol. 36, 307\u2013314 (2015).","journal-title":"Trends Immunol."},{"key":"225_CR63","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4049\/jimmunol.1601340","volume":"199","author":"L Moreira-Teixeira","year":"2017","unstructured":"Moreira-Teixeira, L. et al. T cell-derived IL-10 impairs host resistance to Mycobacterium tuberculosis infection. J. Immunol. 199, 613\u2013623 (2017).","journal-title":"J. Immunol."},{"key":"225_CR64","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.4049\/jimmunol.181.8.5545","volume":"181","author":"GL Beamer","year":"2008","unstructured":"Beamer, G. L. et al. Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA\/J mice. J. Immunol. 181, 5545\u20135550 (2008).","journal-title":"J. Immunol."},{"issue":"3","key":"225_CR65","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/mi.2011.7","volume":"4","author":"P S Redford","year":"2011","unstructured":"Redford, P. S., Murray, P. J. & O\u2019Garra, A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol. 4, 261\u2013270 (2011).","journal-title":"Mucosal Immunology"},{"key":"225_CR66","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.20171704","volume":"215","author":"JP Huynh","year":"2018","unstructured":"Huynh, J. P. et al. Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection. J. Exp. Med. 215, 1823\u20131838 (2018).","journal-title":"J. Exp. Med."},{"key":"225_CR67","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/art.39962","volume":"69","author":"R Furie","year":"2017","unstructured":"Furie, R. et al. Anifrolumab, an anti-interferon-\u03b1 receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus. Arthritis Rheumatol. 69, 376\u2013386 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"225_CR68","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.4049\/jimmunol.1600584","volume":"197","author":"L Moreira-Teixeira","year":"2016","unstructured":"Moreira-Teixeira, L. et al. Type I IFN inhibits alternative macrophage activation during Mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-\u03b3 signaling. J. Immunol. 197, 4714\u20134726 (2016).","journal-title":"J. Immunol."},{"key":"225_CR69","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00431-006-0339-1","volume":"166","author":"CM Ward","year":"2007","unstructured":"Ward, C. M. et al. Adjunctive treatment of disseminated Mycobacterium avium complex infection with interferon \u03b1-2b in a patient with complete interferon-\u03b3 receptor R1 deficiency. Eur. J. Pediatr. 166, 981\u2013985 (2007).","journal-title":"Eur. J. Pediatr."},{"key":"225_CR70","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1128\/IAI.00592-09","volume":"77","author":"PL Lin","year":"2009","unstructured":"Lin, P. L. et al. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect. Immun. 77, 4631\u20134642 (2009).","journal-title":"Infect. Immun."},{"key":"225_CR71","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nri.2017.69","volume":"17","author":"AM Cadena","year":"2017","unstructured":"Cadena, A. M., Fortune, S. M. & Flynn, J. L. Heterogeneity in tuberculosis. Nat. Rev. Immunol. 17, 691\u2013702 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"225_CR72","doi-asserted-by":"publisher","first-page":"5831","DOI":"10.1128\/IAI.71.10.5831-5844.2003","volume":"71","author":"SV Capuano III","year":"2003","unstructured":"Capuano, S. V. III et al. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect. Immun. 71, 5831\u20135844 (2003).","journal-title":"Infect. Immun."},{"key":"225_CR73","doi-asserted-by":"publisher","first-page":"E964","DOI":"10.1073\/pnas.1711853115","volume":"115","author":"H Esmail","year":"2018","unstructured":"Esmail, H. et al. Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis. Proc. Natl. Acad. Sci. USA 115, E964\u2013E973 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"225_CR74","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","volume":"387","author":"DE Zak","year":"2016","unstructured":"Zak, D. E. et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet 387, 2312\u20132322 (2016).","journal-title":"Lancet"},{"key":"225_CR75","first-page":"942","volume":"12","author":"S Charalambous","year":"2008","unstructured":"Charalambous, S. et al. Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int. J. Tuberc. Lung Dis. 12, 942\u2013948 (2008).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"225_CR76","doi-asserted-by":"publisher","first-page":"e0144487","DOI":"10.1371\/journal.pone.0144487","volume":"10","author":"P Uys","year":"2015","unstructured":"Uys, P. et al. The risk of tuberculosis reinfection soon after cure of a first disease episode is extremely high in a hyperendemic community. PLoS One 10, e0144487 (2015).","journal-title":"PLoS One"},{"key":"225_CR77","doi-asserted-by":"crossref","unstructured":"van Helden, P. D., Warren, R. M. & Uys, P. Predicting reinfection in tuberculosis. J. Infect. Dis. 197, 172\u2013173 (2008).","DOI":"10.1086\/523829"},{"key":"225_CR78","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1164\/rccm.200503-449OC","volume":"172","author":"A Rie van","year":"2005","unstructured":"van Rie, A. et al. Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. Am. J. Respir. Crit. Care Med. 172, 636\u2013642 (2005).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"225_CR79","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1056\/NEJM199910143411602","volume":"341","author":"A Rie van","year":"1999","unstructured":"van Rie, A. et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N. Engl. J. Med. 341, 1174\u20131179 (1999).","journal-title":"N. Engl. J. Med."},{"key":"225_CR80","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1086\/315054","volume":"180","author":"A Rie van","year":"1999","unstructured":"van Rie, A. et al. Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling \u201cstrain W\u201d among noninstitutionalized, human immunodeficiency virus-seronegative patients. J. Infect. Dis. 180, 1608\u20131615 (1999).","journal-title":"J. Infect. Dis."},{"key":"225_CR81","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1164\/rccm.200409-1200OC","volume":"171","author":"S Verver","year":"2005","unstructured":"Verver, S. et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am. J. Respir. Crit. Care Med. 171, 1430\u20131435 (2005).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"225_CR82","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1164\/rccm.200305-714OC","volume":"169","author":"RM Warren","year":"2004","unstructured":"Warren, R. M. et al. Patients with active tuberculosis often have different strains in the same sputum specimen. Am. J. Respir. Crit. Care Med. 169, 610\u2013614 (2004).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"225_CR83","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1378\/chest.09-2350","volume":"137","author":"R Diel","year":"2010","unstructured":"Diel, R., Loddenkemper, R. & Nienhaus, A. Evidence-based comparison of commercial interferon-\u03b3 release assays for detecting active TB: a metaanalysis. Chest 137, 952\u2013968 (2010).","journal-title":"Chest"},{"key":"225_CR84","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.it.2016.09.007","volume":"37","author":"P Elkington","year":"2016","unstructured":"Elkington, P., Tebruegge, M. & Mansour, S. Tuberculosis: an infection-initiated autoimmune disease? Trends Immunol. 37, 815\u2013818 (2016).","journal-title":"Trends Immunol."},{"key":"225_CR85","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1164\/rccm.201706-1248LE","volume":"196","author":"K Clayton","year":"2017","unstructured":"Clayton, K., Polak, M. E., Woelk, C. H. & Elkington, P. Gene expression signatures in tuberculosis have greater overlap with autoimmune diseases than with infectious diseases. Am. J. Respir. Crit. Care Med. 196, 655\u2013656 (2017).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"225_CR86","unstructured":"Mourik, B. C., Lubberts, E., de Steenwinkel, J. E. M., Ottenhoff, T. H. M. & Leenen, P. J. M. Interactions between type 1 interferons and the Th17 response in tuberculosis: lessons learned from autoimmune diseases. Front. Immunol. 8, 294 (2017)."},{"key":"225_CR87","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1164\/rccm.201106-1143OC","volume":"184","author":"LL Koth","year":"2011","unstructured":"Koth, L. L. et al. Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. Am. J. Respir. Crit. Care Med. 184, 1153\u20131163 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"225_CR88","doi-asserted-by":"publisher","first-page":"e1001538","DOI":"10.1371\/journal.pmed.1001538","volume":"10","author":"M Kaforou","year":"2013","unstructured":"Kaforou, M. et al. Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med. 10, e1001538 (2013).","journal-title":"PLoS Med."},{"key":"225_CR89","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1056\/NEJMoa1303657","volume":"370","author":"ST Anderson","year":"2014","unstructured":"Anderson, S. T. et al. Diagnosis of childhood tuberculosis and host RNA expression in Africa. N. Engl. J. Med. 370, 1712\u20131723 (2014).","journal-title":"N. Engl. J. Med."},{"key":"225_CR90","doi-asserted-by":"publisher","first-page":"86","DOI":"10.15252\/emmm.201505790","volume":"8","author":"J Maertzdorf","year":"2016","unstructured":"Maertzdorf, J. et al. Concise gene signature for point-of-care classification of tuberculosis. EMBO Mol. Med. 8, 86\u201395 (2016).","journal-title":"EMBO Mol. Med."},{"key":"225_CR91","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S2213-2600(16)00048-5","volume":"4","author":"TE Sweeney","year":"2016","unstructured":"Sweeney, T. E., Braviak, L., Tato, C. M. & Khatri, P. Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. Lancet Respir. Med. 4, 213\u2013224 (2016).","journal-title":"Lancet Respir. Med."},{"key":"225_CR92","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.tube.2018.01.002","volume":"109","author":"S Leong","year":"2018","unstructured":"Leong, S. et al. Existing blood transcriptional classifiers accurately discriminate active tuberculosis from latent infection in individuals from south India. Tuberculosis 109, 41\u201351 (2018).","journal-title":"Tuberculosis"},{"key":"225_CR93","doi-asserted-by":"crossref","first-page":"112907","DOI":"10.18632\/oncotarget.22889","volume":"8","author":"L Pan","year":"2017","unstructured":"Pan, L. et al. Genome-wide transcriptional profiling identifies potential signatures in discriminating active tuberculosis from latent infection. Oncotarget 8, 112907\u2013112916 (2017).","journal-title":"Oncotarget"},{"key":"225_CR94","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1128\/JCM.01990-15","volume":"54","author":"ND Walter","year":"2016","unstructured":"Walter, N. D. et al. Blood transcriptional biomarkers for active tuberculosis among patients in the United States: a case-control study with systematic cross-classifier evaluation. J. Clin. Microbiol. 54, 274\u2013282 (2016).","journal-title":"J. Clin. Microbiol."},{"key":"225_CR95","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1016\/S2213-2600(16)30038-8","volume":"4","author":"ND Walter","year":"2016","unstructured":"Walter, N. D., Reves, R. & Davis, J. L. Blood transcriptional signatures for tuberculosis diagnosis: a glass half-empty perspective. Lancet Respir. Med. 4, e28 (2016).","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"225_CR96","doi-asserted-by":"publisher","first-page":"e1002238","DOI":"10.1371\/journal.pmed.1002238","volume":"14","author":"Helen Cox","year":"2017","unstructured":"Cox, H. et al. Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB\/RIF in South Africa: a retrospective cohort study. PLoS Med. 14, e1002238 (2017).","journal-title":"PLOS Medicine"},{"key":"225_CR97","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2471\/BLT.14.138925","volume":"93","author":"HS Cox","year":"2015","unstructured":"Cox, H. S. et al. The need to accelerate access to new drugs for multidrug-resistant tuberculosis. Bull. World Health Organ. 93, 491\u2013497 (2015).","journal-title":"Bull. World Health Organ."},{"key":"225_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1923-2","volume":"16","author":"ND Bang","year":"2016","unstructured":"Bang, N. D. et al. Clinical presentations, diagnosis, mortality and prognostic markers of tuberculous meningitis in Vietnamese children: a prospective descriptive study. BMC Infect. Dis. 16, 573 (2016).","journal-title":"BMC Infect. Dis."},{"key":"225_CR99","unstructured":"Suliman, S. et al. Four-gene pan-African blood signature predicts progression to tuberculosis. Am. J. Respir. Crit. Care Med. (2018)."},{"key":"225_CR100","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12269","volume":"264","author":"JM Cliff","year":"2015","unstructured":"Cliff, J. M., Kaufmann, S. H., McShane, H., van Helden, P. & O\u2019Garra, A. The human immune response to tuberculosis and its treatment: a view from the blood. Immunol. Rev. 264, 88\u2013102 (2015).","journal-title":"Immunol. Rev."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41590-018-0225-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41590-018-0225-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41590-018-0225-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:50:23Z","timestamp":1684605023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-018-0225-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,17]]},"references-count":100,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["225"],"URL":"https:\/\/doi.org\/10.1038\/s41590-018-0225-9","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,17]]},"assertion":[{"value":"29 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. Patents previously held by A.O.G. on the use of the blood transcriptome for the diagnosis of tuberculosis have lapsed and have been discontinued. M.R. is an employee of BioM\u00e9rieux, which has not filed patents related to this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}